Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution (Review).
about
A novel EGFR-TKI inhibitor (cAMP-H3BO3complex) combined with thermal therapy is a promising strategy to improve lung cancer treatment outcomes.[Aberrant Expression of Rb and pRb-780, pRb-795 in Lung Adenocarcinoma Patients with EGFR Mutations and Their Clinical Significance].Identification of RFC5 as a novel potential prognostic biomarker in lung cancer through bioinformatics analysis
P2860
Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution (Review).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Determining EGFR-TKI sensitivi ...... plexity and solution (Review).
@en
Determining EGFR-TKI sensitivi ...... ancer: Perplexity and solution
@nl
type
label
Determining EGFR-TKI sensitivi ...... plexity and solution (Review).
@en
Determining EGFR-TKI sensitivi ...... ancer: Perplexity and solution
@nl
prefLabel
Determining EGFR-TKI sensitivi ...... plexity and solution (Review).
@en
Determining EGFR-TKI sensitivi ...... ancer: Perplexity and solution
@nl
P2093
P2860
P921
P356
P1433
P1476
Determining EGFR-TKI sensitivi ...... plexity and solution (Review).
@en
P2093
Naixin Liang
Shanqing Li
P2860
P304
P356
10.3892/OR.2017.5409
P50
P5008
P577
2017-01-30T00:00:00Z
2017-03-01T00:00:00Z